NGNicolás María González-Senac

Nicolás María González-Senac

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nicolás María González-Senac has a total of 55 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A survey among geriatricians on geriatric oncology and geriatric surgical oncology models in Europe

    by Paula Sobrini-Morillo, Isabelle Moens, Alfonso Cruz-Jentoft, Andrea Sebastiano Ciccone, Jugdeep K. Dhesi, Nicolas M. Gonzalez-Senac, Marije Hamaker, Cecilia Lund, Francesco Mattace-Raso, Nina Neuendorff, et al.

    Purpose: To provide an up-to-date overview of geriatricians’ involvement in oncological and onco-surgical care for older adults across Europe. Methods: An anonymous 35-item online survey was distributed via (inter)national societies between 10 April and 23 May 2025. The responses were summarized, and associations between comprehensive geriatric assessment (CGA) outputs, participation in oncological multidisciplinary team (MDT) meetings, and involvement in treatment decision-making were explored. Results: A total of 2160 responses were received from 37 countries. Further analysis included 395 geriatrician/internal medicine respondents with > 25% survey completion from 34 countries. Of them, 19% reported no formal geriatric oncology model; the most common approaches were referral based on clinical judgment (43%) and a two-step pathway (42%). Frailty screening-guided referral occurred in 63%, with the G8 (50%) and Clinical Frailty Scale (32%) being the most commonly used. Among respondents, 30% reported routine MDT attendance, and 20% reported involvement in treatment decisions. In exploratory analyses, routine MDT participation was associated with active treatment decision-making (aOR 6.01, 95% CI 3.08–11.7), CGA-based recommendations addressing both geriatric domains and oncological treatment (aOR 5.81, 95% CI 3.16–10.7), and positive feedback from oncology/surgery teams (aOR 3.75, 95% CI 1.96–7.14; all p < 0.001). Only 39% of respondents were involved in inpatient surgical oncology care, with liaison models predominating (37%). Conclusion: Geriatric oncology and geriatric surgical oncology remain unevenly implemented across Europe. Standardized pathways, training, and MDT integration may improve equity of care for older adults with cancer.

  • Why do residents choose to specialize in geriatric medicine?

    by Magdalena Linge Martín, Gema Somoza Fernández, Nicolas M. Gonzalez-Senac, Amaya Capón Sáez, Jesús Mateos-Nozal, Alfonso J. Cruz-Jentoft, Francisco José Tarazona Santalbina, José Antonio Serra-Rexach

    Key summary points AbstractSection Aim To explore the reasons behind the choice of Geriatric Medicine as a specialty among medical residents. AbstractSection Findings Interest in Geriatric Medicine is shaped by both personal factors and elements directly related to the specialty and the characteristics of the older adult population. Training in Geriatrics, encompassing both theoretical and practical components, appears to help reframe the complexity of geriatric patients as a stimulating aspect of the field. AbstractSection Message Promoting a comprehensive education in Geriatric Medicine during medical training may increase the appeal of the specialty as a career path.


  • Open Access

    Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022

    by Colm Mac Eochagain, Robert Power, Christine Sam, Nicolas M Gonzalez-Senac, Darren Walsh, Mukul Roy, Nicolò Matteo Luca Battisti

    Immune checkpoint inhibitors (ICI) have transformed the management of cancer, particularly for older adults, who constitute a majority of the global cancer patient population. This study aimed to assess the inclusion, characteristics, and reporting of older adults enrolled in Food and Drug Administration (FDA) registration clinical trials of ICI between 2018 and 2022. Clinical trials of ICI leading to an FDA approval in solid tumor oncology between 2018 and 2022 were included. Primary study reports and all available secondary publications were assessed. The availability and completeness of older subgroup data for protocol-defined clinical efficacy endpoints, health-related quality of life (HRQOL) and toxicity outcomes, and baseline characteristics were assessed according to predefined criteria which categorized reporting completeness hierarchically in relation to the availability of published data, including effect size, sample size, and measures of precision. 53 registration trials were included, involving a total of 37,094 participants. Most trials (64.2%) were of ICI combination therapy. 42.3% of patients were aged≥65 years; 11.1% were aged≥75. No trials specified an upper age limit for eligibility. 98.1% of trials excluded patients with European Cooperative Oncology Group performance status>1. 87.2% of primary efficacy endpoints and 17.9% of secondary efficacy endpoints were reported completely for older adults. Five studies (9.4%) reported baseline characteristics, three (6.1%) reported HRQOL assessments, and four (7.5%) reported toxicity outcomes completely among older subgroups. No trials conducted baseline geriatric assessments or reported geriatric-specific symptoms or quality of life scales. This analysis highlights significant deficits in the enrollment and reporting of older subgroups in pivotal trials of ICI therapy. The findings highlight an urgent need for improved reporting and inclusion standards in clinical trials of ICI to better inform treatment decisions for older adults.


  • Effects of reminiscence therapy on anxiety and depression during acute hospitalization in older patients: Controlled study

    by Nicolas M. Gonzalez‐Senac, Gema Somoza‐Fernandez, Esther Ocaña Ramirez, Vicente Romero‐Estarlich, Francisco J. Ortiz‐Alonso, Jose A. Serra‐Rexach, Maria T. Vidan

    Background/Objectives: Hospitalization due to acute illness in older patients is often associated with anxiety or depressive symptoms. In these circumstances, given that pharmacologic treatment should be avoided to reduce interactions with ongoing medication regimes, psychotherapy techniques should be considered. The purpose of this study was to evaluate the effectiveness of group reminiscence therapy (RT) on the reduction of anxiety and depressive symptoms in acutely hospitalized older patients. Methods: Controlled and prospective study conducted on the Acute Geriatric Unit of a university hospital. Patients included in the intervention group (RT Group) attended a group session focused on RT, whereas those included in the control group (UC) received usual hospital care. Exclusion criteria were severe cognitive impairment, impossibility to mobilize, and clinical/hemodynamic instability. The intervention was based on a multi‐task daily group session of reminiscence activities. The severity of anxiety (Hamilton Anxiety Rating Scale, HAM‐A), depressive symptoms (15‐item Geriatric Depression Scale, GDS‐15), loneliness (ESTE‐II social loneliness scale), and fear of death (Collet‐Lester scale) was assessed at admission and discharge in both groups. Results: The intervention was effective in reducing the proportion of patients with anxiety and depressive symptoms during hospitalization. The proportion of patients with moderate–severe anxiety at discharge was 32.1% in the UC and 13.4% in the RT Group ( p < 0.001), whereas the proportion of patients with depressive symptoms at discharge was 49.1% in the UC and 19.5% in the RT Group ( p < 0.001). The intervention was independently associated with benefits on anxiety levels (RR 2.45, 95% CI 1.83–3.28) and depression (RR 3.71, 95% CI 2.22–6.19) at discharge. No differences were found in loneliness or fear of death. Conclusions: A group reminiscence activity reduces the proportion of patients with anxiety and depressive symptoms during hospitalization for an acute disease. Absolute changes in both anxiety and depression scores, even though significant, were relatively small.


  • Prevalence of geriatric syndromes and study of early post-surgical functionality in elderly patients with colorectal cancer and surgical indication

    by N.M. Gonzalez-Senac, M.L. Cruz-Arnes, C. Paniagua Carrasco, J. Mayordomo-Cava, M.T. Vidan, J.A. Serra-Rexach

  • Open Access

    Colorectal Cancer in Elderly Patients with Surgical Indication: State of the Art, Current Management, Role of Frailty and Benefits of a Geriatric Liaison

    by Nicolás M. González-Senac, Jennifer Mayordomo-Cava, Angela Macías-Valle, Paula Aldama-Marín, Sara Majuelos González, María Luisa Cruz Arnés, Luis M. Jiménez-Gómez, María T. Vidán-Astiz, José Antonio Serra-Rexach

    Six out of every 10 new colorectal cancer (CRC) diagnoses are in people over 65 years of age. Current standardized surgical approaches have proved to be tolerable on the elderly population, although post-operative complications are more frequent than in the younger CRC population. Frailty is common in elderly CRC patients with surgical indication, and it appears to be also associated with an increase of post-operative complications. Fast-track pathways have been developed to assure and adequate post-operative recovery, but comprehensive geriatric assessments (CGA) are still rare among the preoperative evaluation of elderly CRC patients. This review provides a thorough study of the effects that a CGA assessment and a geriatric intervention have in the prognosis of CRC elderly patients with surgical indication.


  • Demencia rápidamente progresiva por virus BK en mujer octogenaria

    by M. Angeles García-Alhambra, Nicolás María González-Senac, Carmen Guerrero Márquez, Javier Orcajo

  • Encefalopatía en paciente anciano tras diagnóstico de gripe por el virus influenza B: a propósito de un caso

    by Nicolás M. González-Senac, Gema Somoza Fernández, María Ángeles García Alhambra